ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $281,229 (100.0% shares, 0.0% debt)

Holdings (30)

IOVA IOVANCE BIOTHERAPEUTICS INC 21.2%

Value ($000) $59,503 Shares 2,426,701 Est. Cost $7.92 Unrealized +90.3%

XBI SPDR SERIES TRUST 6.2%

Value ($000) $17,542 Shares 200,000 Est. Cost — Unrealized —

— KADMON HLDGS INC 5.6%

Value ($000) $15,692 Shares 7,617,500 Est. Cost $3.68 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 5.0%

Value ($000) $14,149 Shares 1,190,000 Est. Cost $6.75 Unrealized —

VCYT VERACYTE INC 4.9%

Value ($000) $13,728 Shares 481,500 Est. Cost $10.93 Unrealized +128.6%

ARWR ARROWHEAD PHARMACEUTICALS IN 4.5%

Value ($000) $12,680 Shares 478,500 Est. Cost $20.04 Unrealized +9.5%

ARVN ARVINAS INC 4.3%

Value ($000) $12,116 Shares 551,000 Est. Cost $19.15 Unrealized +9.7%

ARGX ARGENX SE 4.1%

Value ($000) $11,468 Shares 81,000 Est. Cost $78.55 Unrealized —

AXSM AXSOME THERAPEUTICS INC 4.0%

Value ($000) $11,266 Shares 437,500 Est. Cost $20.04 Unrealized 0.0%

— BIOHAVEN PHARMACTL HLDG CO L 4.0%

Value ($000) $11,166 Shares 255,000 Est. Cost $40.66 Unrealized —

INSM INSMED INC 4.0%

Value ($000) $11,149 Shares 435,500 Est. Cost $26.21 Unrealized +6.3%

MIST MILESTONE PHARMACEUTICALS IN 3.3%

Value ($000) $9,421 Shares 347,000 Est. Cost $20.62 Unrealized 0.0%

— ATHENEX INC 3.3%

Value ($000) $9,356 Shares 472,500 Est. Cost $19.80 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 2.9%

Value ($000) $8,132 Shares 671,500 Est. Cost $9.94 Unrealized +11.3%

VRAYQ VIEWRAY INC 2.6%

Value ($000) $7,422 Shares 842,500 Est. Cost $7.22 Unrealized +12.4%

XENE XENON PHARMACEUTICALS INC 2.5%

Value ($000) $6,917 Shares 701,500 Est. Cost $7.43 Unrealized +28.7%

— MIRATI THERAPEUTICS INC 2.3%

Value ($000) $6,438 Shares 62,500 Est. Cost $83.51 Unrealized —

AUPH AURINIA PHARMACEUTICALS INC 2.2%

Value ($000) $6,152 Shares 935,000 Est. Cost $6.37 Unrealized 0.0%

— DICERNA PHARMACEUTICALS INC 2.2%

Value ($000) $6,056 Shares 384,500 Est. Cost $14.81 Unrealized —

IRIX IRIDEX CORP 1.9%

Value ($000) $5,329 Shares 1,171,300 Est. Cost $11.40 Unrealized -57.2%

KALV KALVISTA PHARMACEUTICALS INC 1.7%

Value ($000) $4,718 Shares 213,000 Est. Cost $16.48 Unrealized +42.3%

FOLD AMICUS THERAPEUTICS INC 1.6%

Value ($000) $4,368 Shares 350,000 Est. Cost $12.69 Unrealized 0.0%

CRSP CRISPR THERAPEUTICS AG 1.3%

Value ($000) $3,721 Shares 79,000 Est. Cost $39.97 Unrealized 0.0%

— IMMUNOMEDICS INC 1.1%

Value ($000) $3,121 Shares 225,000 Est. Cost $13.68 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 0.8%

Value ($000) $2,190 Shares 50,000 Est. Cost $40.66 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 0.8%

Value ($000) $2,190 Shares 50,000 Est. Cost $40.66 Unrealized —

— ASSEMBLY BIOSCIENCES INC 0.8%

Value ($000) $2,131 Shares 158,000 Est. Cost $16.58 Unrealized —

DHR DANAHER CORPORATION 0.6%

Value ($000) $1,644 Shares 11,500 Est. Cost $114.95 Unrealized 0.0%

— CHIMERIX INC 0.4%

Value ($000) $1,210 Shares 280,000 Est. Cost $4.32 Unrealized —

— CHEMBIO DIAGNOSTICS INC 0.1%

Value ($000) $254 Shares 41,667 Est. Cost $7.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IOVA	IOVANCE BIOTHERAPEUTICS INC	2,426,701	$59,503	21.2%	$7.92	+90.3%	COM	462260100
XBI	SPDR SERIES TRUST	200,000	$17,542	6.2%	—	—	Put	78464A870
—	KADMON HLDGS INC	7,617,500	$15,692	5.6%	$3.68	—	COM	48283N106
—	ADVERUM BIOTECHNOLOGIES INC	1,190,000	$14,149	5.0%	$6.75	—	COM	00773U108
VCYT	VERACYTE INC	481,500	$13,728	4.9%	$10.93	+128.6%	COM	92337F107
ARWR	ARROWHEAD PHARMACEUTICALS IN	478,500	$12,680	4.5%	$20.04	+9.5%	COM	04280A100
ARVN	ARVINAS INC	551,000	$12,116	4.3%	$19.15	+9.7%	COM	04335A105
ARGX	ARGENX SE	81,000	$11,468	4.1%	$78.55	—	SPONSORED ADR	04016X101
AXSM	AXSOME THERAPEUTICS INC	437,500	$11,266	4.0%	$20.04	0.0%	COM	05464T104
—	BIOHAVEN PHARMACTL HLDG CO L	255,000	$11,166	4.0%	$40.66	—	COM	G11196105
INSM	INSMED INC	435,500	$11,149	4.0%	$26.21	+6.3%	COM PAR $.01	457669307
MIST	MILESTONE PHARMACEUTICALS IN	347,000	$9,421	3.3%	$20.62	0.0%	COM	59935V107
—	ATHENEX INC	472,500	$9,356	3.3%	$19.80	—	COM	04685N103
PTGX	PROTAGONIST THERAPEUTICS INC	671,500	$8,132	2.9%	$9.94	+11.3%	COM	74366E102
VRAYQ	VIEWRAY INC	842,500	$7,422	2.6%	$7.22	+12.4%	COM	92672L107
XENE	XENON PHARMACEUTICALS INC	701,500	$6,917	2.5%	$7.43	+28.7%	COM	98420N105
—	MIRATI THERAPEUTICS INC	62,500	$6,438	2.3%	$83.51	—	COM	60468T105
AUPH	AURINIA PHARMACEUTICALS INC	935,000	$6,152	2.2%	$6.37	0.0%	COM	05156V102
—	DICERNA PHARMACEUTICALS INC	384,500	$6,056	2.2%	$14.81	—	COM	253031108
IRIX	IRIDEX CORP	1,171,300	$5,329	1.9%	$11.40	-57.2%	COM	462684101
KALV	KALVISTA PHARMACEUTICALS INC	213,000	$4,718	1.7%	$16.48	+42.3%	COM	483497103
FOLD	AMICUS THERAPEUTICS INC	350,000	$4,368	1.6%	$12.69	0.0%	COM	03152W109
CRSP	CRISPR THERAPEUTICS AG	79,000	$3,721	1.3%	$39.97	0.0%	NAMEN AKT	H17182108
—	IMMUNOMEDICS INC	225,000	$3,121	1.1%	$13.68	—	COM	452907108
—	BIOHAVEN PHARMACTL HLDG CO L	50,000	$2,190	0.8%	$40.66	—	Put	G11196105
—	BIOHAVEN PHARMACTL HLDG CO L	50,000	$2,190	0.8%	$40.66	—	Call	G11196105
—	ASSEMBLY BIOSCIENCES INC	158,000	$2,131	0.8%	$16.58	—	COM	045396108
DHR	DANAHER CORPORATION	11,500	$1,644	0.6%	$114.95	0.0%	COM	235851102
—	CHIMERIX INC	280,000	$1,210	0.4%	$4.32	—	COM	16934W106
—	CHEMBIO DIAGNOSTICS INC	41,667	$254	0.1%	$7.05	—	COM NEW	163572209